Xinting Lv
Hangzhou, 311399, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Progress in bioorthogonal chemistry for prodrug activation and imaging.
Journal: European journal of medicinal chemistry
Published: March 27, 2026
Arteannuin B, a novel NLRP3 inhibitor, suppresses NLRP3 inflammasome in macrophages and alleviates NLRP3-related diseases.
Journal: International immunopharmacology
Published: October 25, 2025
Research productivity and trends in gastric neuroendocrine neoplasms in the early 21st century: a bibliometric and visualized analysis.
Journal: Discover oncology
Published: September 03, 2025
A Hybrid Energy-Based and AI-Based Screening Approach for the Discovery of Novel Inhibitors of AXL.
Journal: ACS medicinal chemistry letters
Published: October 23, 2024
CRISPR-mediated WNK4 point mutation aggravates tumor progression and weakens chemotherapy sensitivity in gastric cancer.
Journal: Histology and histopathology
Published: October 04, 2024
Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases.
Journal: Acta pharmaceutica Sinica. B
Published: March 18, 2024
Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury.
Journal: Bioorganic chemistry
Published: December 24, 2023
Corrigendum to "Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis" [Int. Immunopharmacol. 118 (2023) 110065].
Journal: International immunopharmacology
Published: July 05, 2023
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer.
Journal: Journal of medicinal chemistry
Published: May 23, 2023
Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis.
Journal: International immunopharmacology
Published: January 28, 2023
Discovery of a potent and selective allosteric inhibitor targeting the SHP2 tunnel site for RTK-driven cancer treatment.
Journal: European journal of medicinal chemistry
Published: January 13, 2023
Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3.
Journal: Cell death and differentiation
Published: November 02, 2022
Last Updated: 09/26/2026